NovaBridge Biosciences (NBP) Payables (2018 - 2025)
NovaBridge Biosciences (NBP) reported Payables of $16.8 million for Q4 2025, up 123.35% year-over-year from $7.5 million in Q4 2024, and up 123.35% quarter-over-quarter from $7.5 million in Q4 2024.
NovaBridge Biosciences (NBP) Payables (2018 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 8 years of Payables data on file, last reported at $16.8 million in Q4 2025.
- Payables for Q4 2025 came in at $16.8 million, up 123.35% year-over-year; the trailing twelve-month figure through Dec 2025 was $16.8 million (up 123.35% YoY), and the FY2025 annual result was $16.8 million, up 123.35% from the prior year.
- Payables advanced to $16.8 million in Q4 2025 per NBP's latest filing, from $7.5 million in the prior quarter.
- Over five years, Payables peaked at $102.0 million in Q4 2022 and troughed at $4.3 million in Q2 2023.
- A 5-year average of $46.2 million and a median of $35.3 million in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables slumped 86.01% in 2024, then soared 123.35% in 2025.
- A 5-year view of Payables shows it stood at $92.8 million in 2021, then increased by 9.92% to $102.0 million in 2022, then sank by 47.21% to $53.8 million in 2023, then tumbled by 86.01% to $7.5 million in 2024, then soared by 123.35% to $16.8 million in 2025.
- Business Quant data shows NBP's Payables at $16.8 million in Q4 2025, $7.5 million in Q4 2024, and $53.8 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 34.55 Mn |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | 16.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.82 Mn |
| Dec 31, 2024 | 7.53 Mn |
| Dec 31, 2023 | 53.85 Mn |
| Jun 30, 2023 | 4.28 Mn |
| Dec 31, 2022 | 102.01 Mn |
| Dec 31, 2021 | 92.80 Mn |
| Dec 31, 2020 | 84.58 Mn |
| Dec 31, 2019 | 45.91 Mn |
| Dec 31, 2018 | 21.36 Mn |